|
|
|
Asthma
What is asthma? Asthma is not a disease; it is a collection of symptoms. Commonly described as tightness in the chest, difficulty getting a satisfying breath, swollen inflamed airways and mucous. Why do these symptoms occur? Many people who get asthma will recognise these scenarios.
Each of the three scenarios outlined above have one thing in common. The breathing pattern changed; the rate of breathing increased. This is called hyperventilation. Put simply - breathing more than the body requires for the activity. When this occurs it causes an imbalance of the levels of individual gases within our lungs and our blood. Principally we breathe out too much carbon dioxide. Why does it matter if we breathe out too much carbon dioxide? There is an optimum level of carbon dioxide which our body needs for normal functioning. If we have too little within our system the result will be the onset of symptoms.
How can the Buteyko Institute Method of breathing retraining help? The main aim of the BIM is to teach people to normalise their breathing pattern. When breathing rates are normal, the level of carbon dioxide within the body will be normal and the body will function well; smooth muscle around the airways will stay relaxed, oxygen will move more quickly from the blood to all the cells, mast cells will function appropriately and the mucous membranes of the airways will not be inflamed. On learning the BIM, very quickly participants learn to overcome most asthma symptoms by using the breathing exercises. This enables a reduction in bronchodilator usage (reliever puffers such as Ventolin). Asthma management is improved as fewer symptoms are experienced and therefore less medication is required for optimal control. Most long term asthma sufferers are aware that one puff of short-acting reliever (such as Ventolin) is no longer as effective to relieve symptoms. Another key outcome of the BIM program is an improved sensitivity to short-acting relievers. After retraining of the breathing with BIM short-acting relievers become once more an effective emergency medication. |
Copyright © 2004 Buteyko Solutions
|